DRD1 |
rs4531 or rs4532 |
Chr −5 |
A |
rs4532 is known to reduce the function of the DRD1 gene, which is needed as a “go” drive to activate D1 receptors causing normal dopamine function. |
Batel et al. (2008) [15]. |
DRD2 |
rs1800497 |
Chr-11 |
A |
rs1800497 equates functionally to 30–40% lower density of dopamine D2 receptors resulting hypodopaminergic function |
Noble et al (1991) [8]. |
DRD3 |
rs6280 |
Chr3 |
C |
Rs6280 in D3 causes an imbalance of the DRD3 function and has assiciated with Heroin Dependence. |
Kuo et al. (2014) [16]. |
DRD4 |
48 base repeat VNTR |
Chr 11 exon 3 |
Above 7 R |
Similar to the D2, the VNTR 7 R and above results in a hypodopaminergia due to lower receptor function. |
Van Tol (1998) [17] |
COMT |
rs4680 |
Chr 22 |
G |
Carrying the 9 R allele leads to a high activity of catabolism of dopamine in synapse inducing a hypodopaminergia in the synapse. |
Isir et al. (2008) [18] and Wichers et al. [19] |
OPRM1 |
rs1799971 |
Chr 6 |
G |
The G allele is the risk variant of the MOR 118A>G (p.Asn40Asp; SNP rs1799971) promotes a low dopamine function because there will be a lack of inhibition via the GABA inhibitory control of dopamine release at the reward site Nucleus Accumbens (NAc) inducing hypodopaminergia. |
Ray et al. (2011) [20] |
DAT1 |
40 base repeat VNTR |
Chr 5 exon 15 |
9R |
Carrying the 9 R allele leads to a high activity inducing a hypodopaminergia in the synapse. The DAT1 clears excess dopamine released from the pre-neuron into the synapse and prevents uptake into the receptors on the next neuron. |
Byerley et al. (1993) [21]. |
MOA-A |
30 base repeat VNTR |
Chr X Promotor |
3.5 R, 4R |
The 3.5 R and 4 R variants are more active than 3 R or 5 R. Excessive amounts of dopamine are broken down in the presynaptic neuron which may result is less dopamine availability for release into the synaptic cleft arriers of the 3.5 and 4 R may display hypodopaminergia (low dopamine function). |
Contini et al. (2006) [22]. |
5HTTLPR |
43 base repeat INDEL/VNTR plus rs 25531 |
Chr 17 |
LG, S |
The risk variant has 43 base -pair 5″ insertion/deletion, S′ at SNP rs25531. The long allele results in higher serotonin transporter mRNA transcription in human cell lines., The result is that Serotonin is highly reabsorbed from the synapse into the pre-nerve cell causing low serotonin content in the synapse leading to reduced function. |
Merenakk et al. (2011) [23] and van der Zwaluw et al. (2010) [24]. |
GABRB3 |
CA repeat DNR |
Chr 15 (downstream) |
181 |
GABRA3 gene and the risk variant is CA-repeat, whereby allele 181 results in higher activity. This risk allele if overexpressed will cause low dopamine function hypodopaminergia leading to SUD because of inhibition of dopamine release at reward site |
Namkoong et al. (2008) [25]. |